Caricamento...
Genetically Engineered Multivalent Proteins for Targeted Immunotherapy
Monoclonal antibodies initiated the unprecedented breakthroughs in cancer immunotherapy and are rapidly evolving with multiple therapeutic platforms. One next generation strategy engineers multivalent proteins that ligate single-chain variable fragments targeting cellular effectors, tumor-associated...
Salvato in:
| Pubblicato in: | Clin Cancer Res |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4947414/ https://ncbi.nlm.nih.gov/pubmed/27009744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0246 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|